Biological buffer is an important biochemical agent in biochemical industry, which is widely used in clinical laboratory diagnostic reagents, life science research, pharmaceuticals and biotechnology and many other fields. At present, the manufacturers of the biological buffer industry are still dominated by European and American companies, and the main manufacturers include:Avanto, Thermo Fisher, MerckWait.
China's biological buffer industry started late, but driven by the rapid development of downstream industries such as China's pharmaceutical industry, the biological buffer industry has made great progress in recent years, and the product quality has gradually caught up to the level of developed countries, and the production scale and standardization have gradually improved.
In recent years, with the global pairingVaccines, blood products, recombinant proteins, allergies**, cells**, genes**, living cellsThe demand for cutting-edge biopharmaceuticals is growing, and the biobuffer market has ushered in a period of rapid growth. According to a research report by Fior Markets, the global bio-buffer market size was 5$5.6 billion and is expected to grow at a rate of 7With a compound annual growth rate of 41%, the market size will grow to 9$800 million.
Regionally, North America is the world's largest market for biobuffers, accounting for 41% of the global market size in 201734%。With the rapid development of the pharmaceutical industry in the Asia-Pacific region and the continuous increase in healthcare investment in various countries**, the Asia-Pacific region is expected to maintain 9The compound annual growth rate of 53% is higher than the global growth rate.
Moreover, according to MarketResearch, the global HEPES market size was estimated at USD 53 million in 2021 and is expected to reach USD 72 million by 2028, registering a CAGR of 459%。